<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7889B51C-A007-4938-B374-98BC5FC700ED"><gtr:id>7889B51C-A007-4938-B374-98BC5FC700ED</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:surname>Quint</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902135"><gtr:id>6A4A4E3E-0288-4288-A6E5-F3D30A0E4F86</gtr:id><gtr:title>To investigate the causal roles of environmental factors and viruses on exacerbations of COPD</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902135</gtr:grantReference><gtr:abstractText>Chronic obstructive pulmonary disease (COPD) is a common lung condition most often caused by smoking. Many patients suffer from repeated flare-ups of COPD caused by chest infections. These infections are commonly caused by viruses and are important to treat and ideally prevent. Infections contribute to worsening symptoms of the disease and there is insufficient information about susceptibility to viruses to prevent chest infections or hospital admissions from happening. 

This study will investigate the environmental factors such as pollution and temperature on viruses circulating in the community on every day symptoms and likelihood of catching infections in COPD. Nationally this will be studied using large central databases and then more detailed study will be done at an individual patient level. This information will be of benefit to both patients and health care providers by helping to improve the organisation of health care resources, particularly in the winter and highlight times when patients should be aware of increased symptoms and viral infections. With the future development of new antiviral treatments for COPD infections this information will also help provide information as to when these drugs should be given to maximal effect.</gtr:abstractText><gtr:technicalSummary>Aims and Objectives: The aim of this study is to establish the causal roles of environmental factors and viruses on exacerbations of chronic obstructive pulmonary disease (COPD) by investigating the relationship between ambient temperature, air pollution and circulating viruses on daily symptoms and COPD exacerbations. The specific objectives are; 
1. To quantify the relationship between COPD exacerbations and COPD mortality with 
(a) temperature and other climate factors (such as humidity and sunlight hours) and 
 (b) air pollution 
2. To investigate the impact of environmental factors (ambient temperature and air pollution) on circulating viruses
3. To quantify the relationship between circulating viral levels and COPD exacerbations and mortality
4. To apply the results from Aims 1 to 3- to the detailed symptoms, lung function measurement and viral detection data in the London COPD cohort.
5. To establish to what extent the effect of environmental factors on COPD exacerbations and mortality are mediated or explained by viral infections
 
Methodology: Large scale work based on national computerized clinical data will be complimented by detailed work on Prof Wedzicha?s ongoing cohort of approximately 300 COPD patients who have rich data on both symptoms and viral exposures. Meteorological and pollution data will be obtained from the national network of monitors, outcome measures will be obtained from Hospital Episode Statistics (HES), General Practice Research Database (GPRD), and the Office for National Statistics (mortality). Viral data will be obtained from the Health Protection Agency (HPA), the GPRD (flu consultations and upper respiratory tract infection consultations).

Scientific and Medical Opportunities: COPD is the 4th leading cause of death and prevalence is increasing. Exacerbations (commonly caused by viruses), contribute to disease progression and mortality and are the commonest cause of medical hospital admission in the UK. The forthcomi Clinical Strategy for COPD for England highlights a need to improve the quality of COPD services and decrease health care costs. Although the relationship between environmental factors and COPD exacerbations is already being assessed (Healthy Outlook?), this work adds additional detail regarding daily symptom changes and detailed virus data from the London COPD cohort. With the future development of new antiviral agents, this information may help tailor the use of these drugs to maximal effect. As climate change results in warmer winters, understanding the relationship between environmental factors and circulating respiratory viruses will prepare us for the change in exacerbation patterns likely to occur.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-09-27</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>776625</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Epidemiology</gtr:department><gtr:description>MRC Industry Partnership award</gtr:description><gtr:id>FDCAF076-2AD2-4800-898A-AACCE73DFCE2</gtr:id><gtr:impact>Research is still ongoing.</gtr:impact><gtr:outcomeId>U7ibGLvhmpS-1</gtr:outcomeId><gtr:partnerContribution>GSK have provided both financial input and epidemiological expertise.</gtr:partnerContribution><gtr:piContribution>The objective of this partnership is to improve the recognition and definition of COPD and COPD exacerbations in large databases. I am initially undertaking a validation study, the results of which will be used to improve our definitions of COPD and COPD exacerbations for research purposes within CPRD-GOLD, including when linked HES data and/or supporting documentation are not readily available.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC COPE study with Kings and Cambridge</gtr:description><gtr:id>9E094DCF-EF7A-4BC8-B81B-FC1E9D4C9AF3</gtr:id><gtr:impact>I have been interviewed on the Naked Scientist regarding this program of work but no formal outputs yet. 


http://www.thenakedscientists.com/HTML/podcasts/naked-scientists/show/20141021-1/</gtr:impact><gtr:outcomeId>545b96a50cf1a6.27476681-1</gtr:outcomeId><gtr:partnerContribution>Kings are scaling up the individual level patient data to a population level model. 
Cambridge have designed the sensors in collaboration with a company called Atmospheric Sensors.</gtr:partnerContribution><gtr:piContribution>This is a joint MRC grant on which Ben Barrett at Kings is PI and I am Co-I. I am leading on the COPD patient aspect of the study and have an RA working with me to help with recruitment and follow up. The purpose of the study is to see whether there is a relationship between levels of some outdoor pollutants and worsening of symptoms such as breathlessness, wheezing, or coughing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC COPE study with Kings and Cambridge</gtr:description><gtr:id>A037685B-3B89-4843-BD8B-27918C3B46D9</gtr:id><gtr:impact>I have been interviewed on the Naked Scientist regarding this program of work but no formal outputs yet. 


http://www.thenakedscientists.com/HTML/podcasts/naked-scientists/show/20141021-1/</gtr:impact><gtr:outcomeId>545b96a50cf1a6.27476681-2</gtr:outcomeId><gtr:partnerContribution>Kings are scaling up the individual level patient data to a population level model. 
Cambridge have designed the sensors in collaboration with a company called Atmospheric Sensors.</gtr:partnerContribution><gtr:piContribution>This is a joint MRC grant on which Ben Barrett at Kings is PI and I am Co-I. I am leading on the COPD patient aspect of the study and have an RA working with me to help with recruitment and follow up. The purpose of the study is to see whether there is a relationship between levels of some outdoor pollutants and worsening of symptoms such as breathlessness, wheezing, or coughing.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>RSM talk to patients</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3ED61512-4EEB-4644-ABDF-B7BD16F82B20</gtr:id><gtr:impact>Talk encouraged discussion around COPD management.

Improved patient engagement.</gtr:impact><gtr:outcomeId>545b99c0841343.40701647</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wimbledon High School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EF53B550-20F7-44DE-8790-26ECCE939317</gtr:id><gtr:impact>Discussed epidemiology and research and respiratory medicine

several students approached me for further work experience and expressed an interest in learning more about a career involving epidemiology</gtr:impact><gtr:outcomeId>iwkC88oW4Wf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>COPD 2012 London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1FBA6E56-AA87-4815-865B-1D96ABA52A53</gtr:id><gtr:impact>40 health care professionals attended a meeting on COPD

n/a</gtr:impact><gtr:outcomeId>UsW9x8d6ho4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>media interest</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>36B0E6D0-6C54-4913-A2B9-20A9FF8120E6</gtr:id><gtr:impact>Interview on the radio sparked interest in the study.

I have been approached by members of the public interested in the study.</gtr:impact><gtr:outcomeId>545b98f2f3dee2.05591233</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.thenakedscientists.com/HTML/podcasts/naked-scientists/show/20141021-1/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1398BEB1-2CF0-4193-B72E-8ABE742EB587</gtr:id><gtr:impact>discussed research outputs which sparked questions around management of MI in people with COPD.

Change in local policy around COPD management after an MI</gtr:impact><gtr:outcomeId>545b9a190b44c9.79208306</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple GP visits to discuss research outputs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>660C94FE-898E-4A0A-935C-3198D39D7FFF</gtr:id><gtr:impact>encouraged debate in COPD management and best practice.

changes in local COPD guidelines</gtr:impact><gtr:outcomeId>545b9a8056de10.79876576</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BEF1AFD6-7CF8-4D96-BED7-17E5A95729BD</gtr:id><gtr:impact>Nottingham Epi dept meeting

collaborations and discussions</gtr:impact><gtr:outcomeId>Gaqgo87NWar</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Southampton</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>77AE5148-9343-4675-BAD4-5BDFA6289CCE</gtr:id><gtr:impact>Departmental seminar

collaborations and dicussions</gtr:impact><gtr:outcomeId>Amg9d9o1SR6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BTS summer meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B801E1B-8867-4810-AC00-998BEFA48B11</gtr:id><gtr:impact>Discussed health care structure and management including research examples. Sparked discussion.

thinking around local services</gtr:impact><gtr:outcomeId>545b9ade1b9d52.46550427</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>78570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Lung Foundation</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:fundingRef>RG14-5</gtr:fundingRef><gtr:id>1FD9FC23-075D-40EF-853E-6A38026FD8EC</gtr:id><gtr:outcomeId>545b9762e08c71.69013896</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Respiratory Representative SNOMED-CT project</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>207ACC46-DBE4-47DE-9771-FEB6EA26D475</gtr:id><gtr:impact>Changes in the way Respiratory outpatient visits are coded. Has led to further work with the HSCIC.</gtr:impact><gtr:outcomeId>Tk5Vn5Z14Xu</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Population of the &amp;quot;Right Care Systems Planning Support&amp;quot; run on a Wiki-based web platform developed by Sir Muir Gray's Right Care team to answer ten standard questions for commissioners.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B47B9A0-6265-409F-8CE2-7FCD1EF4EAEA</gtr:id><gtr:outcomeId>MmNwmch2jEb</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Data Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E0778AB-F9CA-4CDE-BA25-8FBC881CC3CA</gtr:id><gtr:outcomeId>LazZPPmmHCc</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>98B2EFDF-305E-41F2-A55E-BFF6A17B39A2</gtr:id><gtr:title>Respiratory Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b5d346166d6.88898705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD1F19B-1F88-45EC-B717-09D1D5C2D694</gtr:id><gtr:title>The Prevalence Of Co-Existing Diseases Associated With The Aetiology Of Bronchiectasis</gtr:title><gtr:parentPublicationTitle>American Thoracic Society Conference Preceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ddeb4b0d25d1d8a565eddbd6154bbd6"><gtr:id>4ddeb4b0d25d1d8a565eddbd6154bbd6</gtr:id><gtr:otherNames>Navaratnam V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b672f4f3939.08577247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26530B3E-09A8-4E9B-9C9D-C1D5F476F504</gtr:id><gtr:title>Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD).</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b1723e0498997675037f550ba7ba764"><gtr:id>3b1723e0498997675037f550ba7ba764</gtr:id><gtr:otherNames>Quint JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>545b6097257bd2.88511997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECC08223-28E1-4E45-B989-F19F39D0E793</gtr:id><gtr:title>Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72598a8ad8925b657492fd5f7e9aa060"><gtr:id>72598a8ad8925b657492fd5f7e9aa060</gtr:id><gtr:otherNames>Rothnie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d575a313ee6.68125850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7B0F768-D53D-4C80-8EAD-9B36554E1496</gtr:id><gtr:title>The risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease: A systematic review</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72598a8ad8925b657492fd5f7e9aa060"><gtr:id>72598a8ad8925b657492fd5f7e9aa060</gtr:id><gtr:otherNames>Rothnie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b64e9033600.09833480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F66B0CC6-8708-4722-9510-BCFA43E2CD33</gtr:id><gtr:title>Relationship between exacerbation frequency and survival post MI in COPD patients</gtr:title><gtr:parentPublicationTitle>European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8948478342fe9926306bd973789ae72e"><gtr:id>8948478342fe9926306bd973789ae72e</gtr:id><gtr:otherNames>Quint Jennifer</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m4Lwjig5fLB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3051A2C9-EE08-468E-819C-8A6F1512413E</gtr:id><gtr:title>Factors associated with COPD exacerbation frequency in a UK primary care cohort</gtr:title><gtr:parentPublicationTitle>European Respiratory Society Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/326ff346b1aa48551fc669e3e806eb4c"><gtr:id>326ff346b1aa48551fc669e3e806eb4c</gtr:id><gtr:otherNames>Mullerova, Hana</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>SNRksDDaUsA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEF8BB12-5E3C-414F-BF44-711CCECB3C3D</gtr:id><gtr:title>Acute Exacerbations Of COPD: Clinical History And Effect Of Frequency And Severity On Risk Of Death</gtr:title><gtr:parentPublicationTitle>AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcea53f218a5723d97b64da1f4435d3c"><gtr:id>fcea53f218a5723d97b64da1f4435d3c</gtr:id><gtr:otherNames>Rothnie K.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5a36016e3bc683.32736559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83814A62-D5CF-4281-B227-52A5C8ACBE6E</gtr:id><gtr:title>Comparison of community-acquired pneumonia incidence estimates using linked and stand-alone electronic health records</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and Drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0adf6436d7bc16495acba8ac31ab3bbf"><gtr:id>0adf6436d7bc16495acba8ac31ab3bbf</gtr:id><gtr:otherNames>Millett ERC</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b62c43f0848.92657063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E1B243B-BCAE-4BC0-A3B8-31F606210ACE</gtr:id><gtr:title>Cardiotoxicity during invasive pneumococcal disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdfa166154c4c71102fb25526faa682"><gtr:id>4bdfa166154c4c71102fb25526faa682</gtr:id><gtr:otherNames>Brown AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>545b5e5d6e5074.91732797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97AE220D-6414-427C-9FC1-C1209C257FD5</gtr:id><gtr:title>COPD atlas</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5736a06bbee2c5df3f8a4ccbbc94e9d"><gtr:id>d5736a06bbee2c5df3f8a4ccbbc94e9d</gtr:id><gtr:otherNames>H Forbes and JK Quint</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>jnH6TBjbbbD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>885CA1D1-FFC1-4190-B5E1-D48C5558DDA6</gtr:id><gtr:title>Keeping 'a chest' of the literature.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b1723e0498997675037f550ba7ba764"><gtr:id>3b1723e0498997675037f550ba7ba764</gtr:id><gtr:otherNames>Quint JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>tD935jPK7s4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EABA431D-C543-46AA-A69D-CA0B2B8B4A63</gtr:id><gtr:title>The Association Between Bronchiectasis And Cardiovascular Disease: A Population Based Study</gtr:title><gtr:parentPublicationTitle>American Thoracic Society Conference Preceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ddeb4b0d25d1d8a565eddbd6154bbd6"><gtr:id>4ddeb4b0d25d1d8a565eddbd6154bbd6</gtr:id><gtr:otherNames>Navaratnam V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b678e45d535.08023580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F07852-369D-404D-968C-913779E52BC3</gtr:id><gtr:title>Effect of ? blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b1723e0498997675037f550ba7ba764"><gtr:id>3b1723e0498997675037f550ba7ba764</gtr:id><gtr:otherNames>Quint JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>bbZiTPLbH8m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>966209FF-1028-4442-A9F9-561F48FCF675</gtr:id><gtr:title>Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72598a8ad8925b657492fd5f7e9aa060"><gtr:id>72598a8ad8925b657492fd5f7e9aa060</gtr:id><gtr:otherNames>Rothnie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>585d3b37dcab35.66889366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0642DC48-4647-42C5-A7A4-2F120C36F3AD</gtr:id><gtr:title>Muir Grey Right Care wiki on COPD (10 questions) for GP commissioners</gtr:title><gtr:parentPublicationTitle>Right care wiki</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1630abae98a58df59722c89ce39ec955"><gtr:id>1630abae98a58df59722c89ce39ec955</gtr:id><gtr:otherNames>Quint Jennfier</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>DoYU81hizAu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7E71585-5EB0-48A8-92C0-55E08D0E6929</gtr:id><gtr:title>Factors Associated With Developing Type 2 Diabetes Mellitus In COPD Patients</gtr:title><gtr:parentPublicationTitle>American Thoracic Society Conference Preceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f693848f513f949610636e2957e84029"><gtr:id>f693848f513f949610636e2957e84029</gtr:id><gtr:otherNames>Niyomnaitham S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b67f583ec16.41125903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3E4C5CF-4CCA-4556-9B21-517A1B188482</gtr:id><gtr:title>Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b1723e0498997675037f550ba7ba764"><gtr:id>3b1723e0498997675037f550ba7ba764</gtr:id><gtr:otherNames>Quint JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>585d68cda36780.20326952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34C8D238-CAAF-40E2-ABD3-CE8C50643F42</gtr:id><gtr:title>Weighing up risk factors for pneumonia: the role of mental illness and benzodiazepine use.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b1723e0498997675037f550ba7ba764"><gtr:id>3b1723e0498997675037f550ba7ba764</gtr:id><gtr:otherNames>Quint JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>nxwPXpHmY8x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50308CC3-EE44-4A0F-9A30-98AA09B70FA1</gtr:id><gtr:title>Improved incidence estimates from linked vs. stand-alone electronic health records.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290722f2dce9b60dbe1e54d3cc744b5a"><gtr:id>290722f2dce9b60dbe1e54d3cc744b5a</gtr:id><gtr:otherNames>Millett ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>585d68c98a8642.02287152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D43F25A-E7E9-4F63-B4D9-150E6F766FBD</gtr:id><gtr:title>Clinical Respiratory Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8948478342fe9926306bd973789ae72e"><gtr:id>8948478342fe9926306bd973789ae72e</gtr:id><gtr:otherNames>Quint Jennifer</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>YQRrwjPZf2y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12AA8E9F-DEE4-42A3-8284-5401798D7227</gtr:id><gtr:title>Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care.</gtr:title><gtr:parentPublicationTitle>International journal of chronic obstructive pulmonary disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72598a8ad8925b657492fd5f7e9aa060"><gtr:id>72598a8ad8925b657492fd5f7e9aa060</gtr:id><gtr:otherNames>Rothnie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1176-9106</gtr:issn><gtr:outcomeId>5a351850cdef20.39463180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F7AF179-C86C-4988-A6F0-AD51C308DCE8</gtr:id><gtr:title>Acute Kidney Injury in Exacerbations of Chronic Obstructive Pulmonary Disease</gtr:title><gtr:parentPublicationTitle>American Thoracic Society Conference Preceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eef9ab6b369aa4b8043bcec3bf55c6f"><gtr:id>6eef9ab6b369aa4b8043bcec3bf55c6f</gtr:id><gtr:otherNames>Barakat MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b66b659b097.73865130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B08580F7-4A9B-47C0-9D57-C69998E0AA5C</gtr:id><gtr:title>M142 The Association Between Exacerbation Frequency And Stroke Risk, In Patients With Copd: A Matched Case-control Study</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c34e27de788030839714481cf43d891"><gtr:id>5c34e27de788030839714481cf43d891</gtr:id><gtr:otherNames>Windsor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b948b2725d4.23764964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60C89A0A-0A59-4598-9EB8-4C8BA3DAF76C</gtr:id><gtr:title>The WISDOM of inhaled corticosteroids in COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab293f5bf407ea0db8fda8af0ad3c93"><gtr:id>cab293f5bf407ea0db8fda8af0ad3c93</gtr:id><gtr:otherNames>Halpin DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>545b5f41f3a620.71428454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D75A0CC-D27E-4A6B-A7F2-0AA0D7141EC2</gtr:id><gtr:title>Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72598a8ad8925b657492fd5f7e9aa060"><gtr:id>72598a8ad8925b657492fd5f7e9aa060</gtr:id><gtr:otherNames>Rothnie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>5675e0bfbb879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5F0D500-DD10-4372-8F54-8FB4307B8C25</gtr:id><gtr:title>Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290722f2dce9b60dbe1e54d3cc744b5a"><gtr:id>290722f2dce9b60dbe1e54d3cc744b5a</gtr:id><gtr:otherNames>Millett ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d551c513a70.26646935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA210B65-8EB9-4E70-AEDC-D33F6CDBAF11</gtr:id><gtr:title>Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database.</gtr:title><gtr:parentPublicationTitle>BMC pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c8a625b8cef2daedeb2b6fdfd769013"><gtr:id>7c8a625b8cef2daedeb2b6fdfd769013</gtr:id><gtr:otherNames>Iwagami M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2466</gtr:issn><gtr:outcomeId>585d5401bd5f89.24232024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F407934-9CA8-4E7A-9BA1-8FA602CBDE15</gtr:id><gtr:title>Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290722f2dce9b60dbe1e54d3cc744b5a"><gtr:id>290722f2dce9b60dbe1e54d3cc744b5a</gtr:id><gtr:otherNames>Millett ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13873_23_24040394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E132BA9-5DFC-4605-8E8B-AFB0C28FE3E6</gtr:id><gtr:title>Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a6e7d08eb100293f2429b7b95dd47f"><gtr:id>e8a6e7d08eb100293f2429b7b95dd47f</gtr:id><gtr:otherNames>M?llerov? H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>545b657841e010.61684266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A526C93B-0A34-4B54-9E67-83CF25776F90</gtr:id><gtr:title>Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7132476b7b5fb7940bb5148803b02ef"><gtr:id>c7132476b7b5fb7940bb5148803b02ef</gtr:id><gtr:otherNames>Plat? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>545b612d5f8512.42591597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA0C0B67-1B42-4B74-99B5-7A64638FC3D4</gtr:id><gtr:title>P172 Time Trends in Incidence and Prevalence of Bronchiectasis in the UK: Abstract P169 Table 1</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e79814f73df35e924ac5fcc8c1ac8707"><gtr:id>e79814f73df35e924ac5fcc8c1ac8707</gtr:id><gtr:otherNames>Quint J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>tgnneS6o2jw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5523BD1C-0DF4-43F2-9435-9FA8AA769868</gtr:id><gtr:title>Exacerbation Frequency in COPD is Associated with Suppressed Bacterial Phagocytosis</gtr:title><gtr:parentPublicationTitle>European Respiratory Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/415217f3555b44afb95697f855d77956"><gtr:id>415217f3555b44afb95697f855d77956</gtr:id><gtr:otherNames>Thomas CMR</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b5fd7226859.20235482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5A53178-1778-4ACA-9D60-D83C0ED2445B</gtr:id><gtr:title>Diverse risk factors identified for post-pneumonia hospitalisation in older individuals did not explain increasing trends.</gtr:title><gtr:parentPublicationTitle>Journal of Clinical Epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0adf6436d7bc16495acba8ac31ab3bbf"><gtr:id>0adf6436d7bc16495acba8ac31ab3bbf</gtr:id><gtr:otherNames>Millett ERC</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545b6344401d70.32611771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CCA2086-EFF0-4A92-92EE-1087F02531CE</gtr:id><gtr:title>Systemic manifestations of chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>British journal of hospital medicine (London, England : 2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d20b14117496d6d0790ac69213ab363f"><gtr:id>d20b14117496d6d0790ac69213ab363f</gtr:id><gtr:otherNames>Warwick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-8460</gtr:issn><gtr:outcomeId>545b5eb8acd3d6.98304215</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902135</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>